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Background: Calprotectin is a heterodimer complex of the S100A8 and S100A9 proteins, and has various
functions as an innate mediator at the sites of inﬂammation.
The aim of this study was to elucidate the roles of calprotectin in the eosinophilic chronic rhinosinusitis
(ECRS).
Methods: Allergen-induced production of calprotectin was evaluated in cultured normal human bron-
chial epithelial (NHBE) cells by ELISA and RT-PCR. We then examined the roles of calprotectin on
Alternaria alternata (Alternaria)-induced production of thymic stromal lymphopoietin (TSLP) and IL-25 in
NHBE cells. The extracellular concentration and allergen-induced secretion of calprotectin in cultured
primary nasal epithelial (PNE) cells were examined and compared between patients with ECRS and non-
eosinophilic chronic rhinosinusitis (NECRS).
Results: Alternaria, house dust mites, protease from Staphylococcus aureus, papain, trypsin, poly-
inosinic:polycytidylic acid and lipopolysaccharide stimulated calprotectin production in the cultured
NHBE cells. The combination of calprotectin and ATP stimulated the production of TSLP and IL-25 in
NHBE cells, and calprotectin stimulated Alternaria-induced production of TSLP and IL-25, which was
suppressed by blocking P2 purinergic receptors and by treatment with siRNA for S100A8, S100A9 or
calprotectin receptors (Toll-like receptor 4 or receptor for advanced glycation end products). Allergen-
induced calprotectin production was signiﬁcantly stimulated in PNE cells from patients with ECRS.
Conclusions: These results indicate that calprotectin enhances the allergen-induced Th2-type inﬂam-
matory responses in airway epithelial cells via the secretion of TSLP and IL-25, and that calprotectin
secreted by the epithelial cells may be involved in the pathogenesis of ECRS.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Calprotectin is a heterodimer complex of the S100A8 and
S100A9 proteins, which aremembers of the S100 family of proteins.
S100 family proteins play various roles in inﬂammation, barrier
function, cancer and innate immunity. Intracellularly, calprotectin
promotes phagocyte migration by promoting the polymerization
and stabilization of tubulin microﬁlaments.1 Extracellular calpro-
tectin is released by neutrophils, monocytes and epithelial cells,yngology, Shiga University of
2, Japan.
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16/j.alit.2016.06.011and exhibits proinﬂammatory functions, such as antimicrobial ac-
tivity against bacteria and fungi, and chemoattractant activity for
neutrophils and monocytes.2 Calprotectin stimulates the produc-
tion of proinﬂammatory cytokines, such as IL-8 and tumor necrosis
factor (TNF)-a, in keratinocytes and airway epithelial cells.3,4 Cal-
protectin also has anti-inﬂammatory and tissue-protective func-
tions as it can inhibit matrix metalloproteinase activity and the
production of reactive oxygen species (ROS).5e7 Thus, calprotectin
may have diverse functions as an innate mediator at the sites of
inﬂammation.
Toll-like receptor 4 (TLR4) and receptor for advanced glycation
end products (RAGE) are speciﬁc receptors for calprotectin.8,9
Calprotectin is found in inﬂammatory tissues and exudates,
including nasal polyps (NPs) and nasal lavage ﬂuids,10 and isvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
n TSLP and IL-25 production from airway epithelial cells, Allergology
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diseases, such as rheumatoid arthritis, autoimmune diseases, in-
ﬂammatory bowel diseases and anti-neutrophil cytoplasmic
autoantibody-associated vasculitis.11e15 However, the role of cal-
protectin in upper airway Th2-type inﬂammation is not well
understood.
Newly discovered epithelial-derived cytokines, i.e., thymic
stromal lymphopoietin (TSLP) and IL-25, induce Th2 cytokine-
dependent inﬂammation, and play key roles in innate and adap-
tive immune responses in airway mucosa.16 Allergens, such as
Alternaria alternata (Alternaria) and house dust mites (HDM),
stimulate the production of TSLP and IL-25 in airway epithelial cells
via protease-activated receptor (PAR)-2,17,18 and TSLP and IL-25
contribute to the initiation and development of allergic inﬂam-
mation in allergic rhinitis, asthma and atopic dermatitis.19e22
Increased expression levels of TSLP and IL-25 have been reported
in the NPs of patients with chronic rhinosinusitis (CRS), and were
shown to exacerbate airway inﬂammation, and contribute to CRS
disease progression.23,24
We hypothesized that calprotectin also plays an important role
in the pathogenesis of eosinophilic chronic rhinosinusitis (ECRS). In
the present study, we evaluated the effects of allergens on the
release of calprotectin from airway epithelial cells, and the role of
calprotectin in the secretion of TSLP and IL-25 induced by an
airborne allergen, Alternaria. Finally, we examined the intracellular
concentration and allergen-induced secretion of calprotectin in
cultured primary nasal epithelial (PNE) cells of CRS patients.Methods
Human subjects
Sixty-six patients with nasal or paranasal sinus diseases were
enrolled in this study (age, 20e77 years; mean age, 49.1 years)
(Table 1). Total IgE, allergen-speciﬁc IgE and blood eosinophil
counts were performed for all the patients. Computed tomography
(CT) assessment by LundeMackay score, the number of the nasal
polyp and endoscopy were performed for the CRS patients. The CRS
patients were classiﬁed into ECRS and non-eosinophilic chronic
rhinosinusitis (NECRS) groups based on JESREC study.25 ECRS was
deﬁned histologically as an averaged eosinophil count of more than
70 per microscopic ﬁeld (400magniﬁcation) in three ﬁelds of the
subepithelial area of NPs; these were counted by two of the authors
independently under light microscopy.25 The diagnosis of asthma
was based on the criteria of the Global Initiative for Asthma pub-
lished in 2006.26 Allergic rhinitis was diagnosed based on theTable 1
Patient characteristics.
Subject characteristics IT
Control AR
Total 8 (6M/2F) 17 (9M/8F
Average age (range) 50.4 (38e66) 33.4 (20e
Asthma (n) 0 5
Atopy (n) 0 17
Blood eosinophils (%) 2.13 ± 1.33 5.17 ± 3.2
Total IgE (U/ml) 76.2 ± 66.9 254.2 ± 2
Speciﬁc IgE (U/ml) HDM 0.13 ± 0.01 17.5 ± 2.2
Alternaria 0.1 0.15 ± 0.0
CT score
Nasal polyps (%) Mono
Multi
IT, inferior turbinate; UT, uncinate process; NP, nasal polyp; AR, allergic rhinitis; ECRS, eo
female; M, male.
P values were evaluated from the ManneWhitney U test comparing 2 groups (IT) and th
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Japan published in 2009.27
Inferior turbinates (IT) were obtained frompatients with allergic
rhinitis (AR) or patients with deﬂected nasal septum during con-
chotomy. NPs of patients with NECRS or ECRS, and uncinate process
tissues (UT) of patients with NECRS or control subjects were ob-
tained during endoscopic sinus surgery. None of the patients had
been treated with systemic corticosteroids or topical corticoste-
roids for at least 4 weeks prior to the surgery. Informed consent was
obtained from all subjects before sampling. This clinical protocol
was approved by the Shiga University of Medical Science Institu-
tional Review Board for Clinical Investigation.
Reagents
Crude allergens of Alternaria and HDM were purchased from
Greer Laboratories (Lenoir, NC, USA). Protease from Staphylococcus
aureus (S. aureus) was obtained from Abnova (Taipei, Taiwan).
Polyinosinic:polycytidylic acid (poly(I:C)) was obtained from
InvivoGen (San Diego, CA, USA). Trypsin from bovine pancreas,
lipopolysaccharide (LPS) from Escherichia coli 0111:B4, adenosine
50-triphosphate disodium salt hydrate (ATP), adenosine 50-
triphosphate periodate oxidized sodium salt (oATP), trans-epox-
ysuccinyl-L-leucylamide (4-guanidino) butane (E-64), 4-
amidinophenylmethanesulfonyl ﬂuoride (APMSF) and nonidet P-
40 were obtained from SigmaeAldrich (St. Louis, MO, USA). Papain
from Carica papaya and suramin were obtained from Calbiochem
(Charlottesville, VA, USA). Recombinant calprotectin was obtained
from Hycult Biotech (Uden, Netherlands). Small interfering RNA
(siRNA) for TLR4, S100A8, and S100A9, and Allstars Negative Con-
trol siRNA were obtained from Qiagen (Hilden, Netherland), and
siRNA for RAGE was obtained from Santa Cruz Biotechnology
(Dallas, TX, USA).
Cell culture, treatment, and transfection
Normal human bronchial epithelial (NHBE) cells were obtained
from Lonza (Walkersville, MD, USA) andwere then transfectedwith
the catalytic component of telomerase, the human catalytic subunit
of the telomerase reverse transcriptase gene, which was kindly
provided by Professor H. Kita (Mayo Clinic, Rochester, MN, USA).
PNE cells were obtained by scratching the UT or NPs by curettage
with a Rhinoprobe (Arlington Scientiﬁc, Inc., Springville, UT, USA).
The NHBE cells or PNE cells were suspended in supplemented basal
epithelial growth medium (BEGM) (Lonza, Basel, Switzerland) and
cultured in a 24-well tissue culture plate (Falcon; Corning, Inc., NY,UT UT or NP NP
Control NECRS ECRS
) 10 (8M/2F) 15 (11M/4F) 16 (14M/2F)
64) 54.7 (46e76) 58.3 (20e77) 53.3 (26e75)
1 2 8
5 5 14
7** 4.10 ± 2.27 5.01 ± 5.01 8.42 ± 5.14*
39.2 209.4 ± 209.4 250.3 ± 258.4 343.6 ± 190.2*
2** 6.21 ± 3.04 1.29 ± 4.01 7.11 ± 2.27
1 0.14 ± 0.11 0.13 ± 0.10 0.70 ± 0.29
8.47 ± 7.17 15.8 ± 6.62*
20% (3/15) 0% (0/16)
40% (6/15) 100% (16/16)
sinophilic chronic rhinosinusitis; NECRS, non-eosinophilic chronic rhinosinusitis; F,
e KruskaleWallis test comparing all 3 groups (UT/NP). *P < 0.05 and **P < 0.01.
n TSLP and IL-25 production from airway epithelial cells, Allergology
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supplements, Alternaria (200 mg/ml), HDM (100 mg/ml), protease
from S. aureus (1 mg/ml), trypsin (10 nM), papain (10 nM), poly(I:C)
(10 mg/ml), LPS (10 mg/ml), ATP (2 mM), or calprotectin (2, 10, 20 mg/
ml) was added, and the cells were incubated for an additional 24 h.
In some experiments, PNECs were seeded (3  104 cells/well) in a
24-well tissue culture plate and grown until they were 80%
conﬂuent by the BEGM®without steroid. Cultured PNECs were also
stimulated for 24 h with HDM (100 mg/ml), Alternaria (200 mg/mL),
protease from S. aureus (1 mg/mL).
Previous reports had noted that high concentrations of fungal
extracts or proteases would produce morphologic changes and
desquamate epithelial cells.28 At the relatively low concentrations
listed above, we did not observe changes in morphology in the
NHBE cells for up to 24 h. In some experiments, oATP (100 mM),
suramin (300 mM), APMSF (100 mM) or E-64 (50 mM) was added to
the NHBE cells 30 min before incubation.
To transfect NHBE cells, HiPerFect (Qiagen) was used according
to the manufacturer's instructions. The cells were transfected with
siRNA against TLR4 (5 nM), RAGE (50 nM), S100A9 (5 nM), or
S100A8 (5 nM), or the Allstars Negative Control siRNA (5 nM).
Knockdown of the target gene mRNA was conﬁrmed by real-time
RT-PCR.Calprotectin and cytokine production and release in NHBE cells and
PNE cells
Cell lysates were prepared by treating unstimulated cultured
PNE cells with nonidet P-40. Cell lysates and cell-free superna-
tants were collected and stored at 20 C until use. ELISA kits
were used to determine the concentrations of TSLP and IL-25
(USCN Life Science Inc., Wuhan, China), calprotectin (BioLegend,
San Diego, CA, USA) and IL-8 (R&D Systems, Minneapolis, MN,
USA). The sensitivity limits of the TSLP, IL-25, calprotectin and IL-8
kits were 5.7 pg/ml, 5.4 pg/ml, 0.62 ng/ml and 31.25 pg/ml,
respectively.RNA isolation and real-time RT-PCR
Total RNA was puriﬁed using a PureLink RNA Mini Kit (Thermo
Fisher Scientiﬁc, MA, USA). cDNAs were synthesized from 1 mg of
each puriﬁed RNA sample using a Transcriptor High Fidelity cDNA
Synthesis Kit (Roche, Basel, Switzerland). Ampliﬁcation and
detection of speciﬁc products were performed using the Light-
Cycler 480 Real-Time PCR system (Roche). The reaction was incu-
bated at 45 C for 60 min and was stopped by heating to 85 C for
5 min. The real-time RT-PCRmixture contained 1 ml of cDNA,10.0 ml
of LightCycler 480 Probe Master (Roche), 0.2 ml of probes, and 0.1 ml
of two primer sets: S100A8 (forward primer: GCCAAGCCTAA
CCGCTATAA; reverse primer: ATGATGCCCACGGACTTG), S100A9
(forward primer: GTGCGAAAAGATCTGCAAAA; reverse primer:
TCAGCTGCTTGTCTGCATTT), TLR4 (forward primer: CTCTCCTGCGTG
AGACCAG; reverse primer: TCCATGCATTGATAAGTAATATTAGGA),
RAGE (forward primer: GGATGAAGGATGTGAGTGACC; reverse
primer: CCCACAGAGCCTGCAGTT) or glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (forward primer: AGCCACATCGCTC
AGACAC; reverse primer: GCCCAATACGACCAAATCC). The reaction
mixtures were topped up to a ﬁnal volume of 20 ml with sterile
water. The real-time RT-PCR protocol was as follows: denaturation
by a hot start at 95 C for 10min, followed by 40 cycles of a two-step
program (denaturation at 95 C for 15 s and annealing/extension at
60 C for 1 min). Transcription was normalized to that of GAPDH in
each sample, and expressed as relative expression compared with
the parallel NHBE cells cultured in the absence of stimuli.Please cite this article in press as: Kato T, et al., The effect of calprotectin o
International (2016), http://dx.doi.org/10.1016/j.alit.2016.06.011Detection of calprotectin by immunohistochemistry and confocal
microscopy
NHBE cells were cultured on Lab-Tek 2 chamber slides (Fisher,
Rochester, NY, USA). The slides were ﬁxed and permeabilized using
Cytoﬁx/Cytoperm reagents for 20 min at 4 C, and then washed
with BD Perm/Wash™ buffer (BD Pharmingen, San Diego, CA, USA)
for 30 min at room temperature. Fixed cells were blocked with 5%
normal rabbit serum (Sigma) for 1 h and stained overnight with
rabbit anti-human calprotectin or normal rabbit IgG (control IgG) at
4 C. For immunoﬂuorescence, the cells were incubated with
ﬂuorescein-conjugated goat anti-rabbit IgG for 2 h at room tem-
perature, washed in BD Perm/Wash™ buffer for 30 min, and
mounted in Vectashield® Mounting Medium with DNA-binding
dye, the nucleus-speciﬁc dye 40-6-diamidino-2-phenylindole
(DAPI) (Vector Laboratories, Burlingame, CA, USA). Fluorescent
images were visualized using an LSM510 confocal microscope (Carl
Zeiss, Jena, Germany), and digital images (512  512 pixels, 800
magniﬁcation) were captured using the KS400 Image Analysis
System (Carl Zeiss). The threshold for each negative control image
was calibrated to a baseline value without positive pixels. All im-
ages were processed using the Zeiss LSM Image Browser (Carl
Zeiss).
Statistical analysis
All data are expressed as the mean ± standard error of the mean
(SEM) from the indicated number of replicates. Two-sided differ-
ences between two samples were analyzed with the Man-
neWhitney U test. Data of three-group comparisons were
evaluated by KruskaleWallis one-way analysis. Values of P < 0.05
were considered signiﬁcant.
Results
Calprotectin production and mRNA expression in NHBE cells are
induced by various allergens, prototypic proteases and TLR agonists
To investigate the mechanisms of calprotectin production in
airway epithelial cells, we examined the effects of environmental
allergens, prototype proteases and TLR ligands on calprotectin
production in NHBE cells. Alternaria, HDM, protease from S. aureus,
papain, trypsin, poly(I:C) and LPS all caused a signiﬁcant increase in
the concentration of calprotectin in the cell-free supernatants
(Fig. 1a). The concentrations of calprotectin continued to increase
after incubation with Alternaria or poly(I:C) for up to 24 h (Fig. 1b).
We next performed an immunoﬂuorescence study of calpro-
tectin in NHBE cells. Calprotectin was weakly detected in the
cytoplasm of resting NHBE cells. After incubationwith Alternaria for
24 h, calprotectin was strongly expressed in the cytoplasm of NHBE
cells (Fig. 1c). Alternaria did not affect the cell morphology of NHBE
cells. Calprotectin is a heterodimer complex of the S100A8 and
S100A9 proteins. The mRNA expressions of S100A8 and S100A9
increased signiﬁcantly in NHBE cells after 8 h of incubation with
Alternaria (Fig. 1d, e). We then used a gene knockdown approach,
and NHBE cells were transfected with siRNAs speciﬁc for S100A8 or
S100A9, or a control siRNA. Transfection with the speciﬁc siRNAs,
but not the control siRNA, signiﬁcantly suppressed the expression
of the target mRNA (Fig. 2a). These knockdown NHBE cells were
then incubated with Alternaria for 24 h, and Alternaria-induced
calprotectin production was signiﬁcantly inhibited in the S100A8-
or S100A9-knockdown cells (Fig. 2b). We then examined whether
the protease activity of allergens, such as Alternaria, HDM and
protease from S. aureus, are involved in allergens-induced calpro-
tectin production. When allergens were pretreated with APMSF, an TSLP and IL-25 production from airway epithelial cells, Allergology
Fig. 1. Calprotectin secretion and mRNA expression in NHBE cells. (a) Calprotectin levels in cell-free supernatants from cells incubated for 24 h with Alternaria (200 mg/ml), HDM
(100 mg/ml), protease from S. aureus (1 mg/ml), papain (10 nM), trypsin (10 nM), poly(I:C) (10 mg/ml) or LPS (10 mg/ml). *P < 0.05; n ¼ 4. (b) Calprotectin levels after 8, 16 or 24 h of
incubation with medium alone (control), poly(I:C) (10 mg/ml) or Alternaria (200 mg/ml). *P < 0.05; n ¼ 4. (c) Immunoﬂuorescent staining of calprotectin in NHBE cells incubated with
medium alone (upper panels) or Alternaria (lower panels) (200 mg/ml) for 24 h. Left panels show nuclear staining with DAPI. Center panels show FITC images with anti-calprotectin
antibody. Right panels show overlays of the left and middle panels. Scale bars indicate 50 mm. (d) S100A8 mRNA expression in NHBE cells after 2, 4 or 8 h of incubation with medium
alone or Alternaria (200 mg/ml). *P < 0.05; n ¼ 4. (e) S100A9 mRNA expression in NHBE cells after 2, 4 or 8 h of incubation with medium alone or Alternaria (200 mg/ml). *P < 0.05;
n ¼ 4.
T. Kato et al. / Allergology International xxx (2016) 1e94serine protease inhibitor, or E-64, a cysteine protease inhibitor,
calprotectin concentrations signiﬁcantly decreased in the cell-free
supernatants, suggesting that the protease activity of allergens
are important in calprotectin production (Fig. 2c).
Calprotectin and ATP stimulate TSLP and IL-25 production in NHBE
cells
We examined the effects of calprotectin on TSLP and IL-25
production in NHBE cells. When NHBE cells were treated with
calprotectin alone (2, 10 or 20 mg/ml), TSLP and IL-25 production
was not stimulated. However, when NHBE cells were treated with
the combination of calprotectin (2, 10 or 20 mg/ml) and ATP (2 mM),Please cite this article in press as: Kato T, et al., The effect of calprotectin o
International (2016), http://dx.doi.org/10.1016/j.alit.2016.06.011TSLP and IL-25 production was signiﬁcantly stimulated in a dose-
dependent manner (Fig. 3a, b). In contrast, IL-8 production was
stimulated by calprotectin alone (10 and 20 mg/ml) (Fig. 3c). Cal-
protectin (2 mg/ml) also signiﬁcantly stimulated Alternaria-induced
production of TSLP and IL-25 in NHBE cells (Fig. 3d, e).
Mechanism of Alternaria-induced TSLP and IL-25 production in
NHBE cells
Alternaria stimulated the production of TSLP and IL-25 in NHBE
cells. To examine the role of the ATP pathway in Alternaria-induced
TSLP and IL-25 production, NHBE cells were incubated with Alter-
naria and antagonists for P2 purinergic receptors, oATP or suramin.n TSLP and IL-25 production from airway epithelial cells, Allergology
Fig. 2. Allergens-induced calprotectin production. (a) The mRNA expression levels of S100A8 and S100A9 in NHBE cells transfected with siRNA against S100A8 (5 nM) or S100A9
(5 nM), or control siRNA (5 nM) for 48 h. Data are expressed as a ratio to the mock-transfected cells without siRNA. *P < 0.05 compared with control cells without siRNA; n ¼ 4. (b)
Effects of siRNA against S100A8 and S100A9 on Alternaria-induced calprotectin production. *P < 0.05; n ¼ 4. (c) Effects of a serine protease inhibitor, APMSF (100 mM), and a cysteine
protease inhibitor, E-64 (50 mM), on allergens-induced calprotectin production. *P < 0.05; n ¼ 4.
T. Kato et al. / Allergology International xxx (2016) 1e9 5P2 receptor antagonists were added to the NHBE cells 30 min
before incubation with Alternaria. Both oATP and suramin signiﬁ-
cantly inhibited Alternaria-induced TSLP and IL-25 production
(Fig. 4a, b), indicating that the ATP pathway is involved in Alter-
naria-induced TSLP and IL-25 production.
TLR4 and RAGE are speciﬁc receptors for calprotectin. We
knocked down TLR4 or RAGE by transfecting NHBE cells with siRNA
for TLR4 or RAGE, respectively, and control cells were transfected
with control siRNA. In the knockdown cells, the expression of the
target mRNA was signiﬁcantly suppressed when compared with
the expression in the control cells (Fig. 5a). Alternaria-induced TSLP
and IL-25 production in cell-free supernatants were signiﬁcantly
inhibited in TLR4- or RAGE-knockdown NHBE cells (Fig. 5b, c).
Moreover, Alternaria-induced TSLP and IL-25 production was
signiﬁcantly inhibited in the S100A8- or S100A9-knockdown NHBE
cells (Fig. 5d, e). These results indicate that calprotectin is involved
in Alternaria-induced production of TSLP and IL-25 in NHBE cells.Calprotectin concentrations in cell lysates and in cell-free
supernatants of cultured PNE cells
The clinical characteristics of the patients are shown in Table 1.
We examined the concentrations of calprotectin in cell lysates and
in cell-free supernatants of cultured PNE cells from the IT of AR
patients or control subjects and from the NPs of NECRS patients or
ECRS patients and from the UT of NECRS patients or control sub-
jects. The intracellular calprotectin concentration in unstimulated
PNE cells from ECRS patients was signiﬁcantly lower than those
from NECRS patients or control subjects (Fig. 6a). There were no
difference between AR patients and control subjects (Fig. 6b).
However, allergen (Alternaria, HDM or protease from S. aureus)-Please cite this article in press as: Kato T, et al., The effect of calprotectin o
International (2016), http://dx.doi.org/10.1016/j.alit.2016.06.011induced calprotectin production was signiﬁcantly stimulated in
PNE cells from ECRS patients when compared with those from
NECRS patients even though the levels of unstimulated calprotectin
release were identical among the groups (Fig. 6c). The allergen-
induced calprotectin production from IT was no difference be-
tween AR patients and control subjects (data not shown). These
results suggest that an increased production of calprotectin may be
involved in the pathogenesis of ECRS.Discussion
Our study provides the ﬁrst evidence that calprotectin plays an
important role in Th2-type airway inﬂammation. We showed that:
1) airborne allergens, such as Alternaria and HDM, stimulate the
production and release of calprotectin in cultured NHBE cells; 2)
the protease activity of allergens is crucial in this process; 3) the
combination of calprotectin and ATP induces the production of
TSLP and IL-25 in NHBE cells; 4) calprotectin stimulates the Alter-
naria-induced production of TSLP and IL-25, which is suppressed by
blocking P2 purinergic receptors and by siRNA for S100A8, S100A9,
TLR4 or RAGE; and 5) allergen-induced calprotectin production is
increased in the PNE cells fromECRS patients. These results indicate
that calprotectin enhances the allergen-induced Th2-type inﬂam-
matory responses in airway epithelial cells via the secretion of TSLP
and IL-25, and that calprotectin produced by the epithelial cells
may be involved in the pathogenesis of ECRS.
S100 protein, ATP, uric acid and high-mobility group box 1
(HMGB1) protein are all examples of damage-associated molecular
patterns (DAMPs). DAMPs, also known as alarmins, are intracellular
molecules that are involved in cellular functions under normal
homeostasis, but are released outside of the cell after cell death,n TSLP and IL-25 production from airway epithelial cells, Allergology
Fig. 3. Effects of calprotectin and ATP on the levels of TSLP, IL-25 and IL-8 in cell-free supernatants from NHBE cells. (aec) Effects of calprotectin and ATP (24 h of incubation) on the
production of TSLP, IL-25 and IL-8. *P < 0.05; n ¼ 4. (d, e) Effects of calprotectin (2 mg/ml) (24 h of incubation) on Alternaria-induced production of TSLP and IL-25. *P < 0.05; n ¼ 4.
T. Kato et al. / Allergology International xxx (2016) 1e96signaling tissue damage.29 Recently, several studies have reported
the relationship between DAMPs and allergic inﬂammation; for
example, signiﬁcantly high concentrations of HMGB1 were found
in the sputa and nasal secretions of patients with asthma, nasal
allergy or CRS.30 RAGE is a speciﬁc receptor of HMGB1, and HDM-
induced allergic responses, including eosinophil inﬁltration and
Th2 cytokine production, were signiﬁcantly suppressed in RAGE/
 mice.31 Increased levels of ATP were observed in the bron-
choalveolar lavage ﬂuids of patients with asthma, and neutraliza-
tion of the ATP inhibited Th2 sensitization to inhaled antigens and
ongoing Th2-type airway inﬂammation.32 Moreover, we alsoFig. 4. Effects of P2 purinergic receptor antagonists, oATP (100 mM) and suramin (300 mM), o
Please cite this article in press as: Kato T, et al., The effect of calprotectin o
International (2016), http://dx.doi.org/10.1016/j.alit.2016.06.011conﬁrmed that calprotectin was induced in airway epithelial cells
after exposure to airborne allergens, indicating that the combina-
tion of calprotectin and ATP as secreted DAMP molecules can
directly induce TSLP and IL-25 production via TLR4 and RAGE in
airway epithelial cells. Taken together, these results suggest that
DAMPs play a role in the development and exacerbation of airway
allergic inﬂammation.
Recently, it was revealed that several mediators and receptors,
including PAR-2, TLR4 and RAGE, are involved in the initiation and
development of innate immune responses against environmental
allergens. The protease activity of allergens and PAR-2 signalingn Alternaria-induced production of TSLP (a) and IL-25 (b) in NHBE cells. *P < 0.05; n ¼ 4.
n TSLP and IL-25 production from airway epithelial cells, Allergology
Fig. 5. Alternaria induced TSLP and IL-25 via calprotectin production in NHBE cells. (a) The mRNA expression levels of TLR4 and RAGE in NHBE cells transfected with siRNA against
TLR4 (5 nM), RAGE (50 nM) or control siRNA (5 nM) for 48 h. Data are expressed as a ratio to the mock-transfected cells without siRNA. *P < 0.05 compared with control cells
without siRNA; n ¼ 4. (b, c) Effects of siRNA against TLR4 and RAGE on Alternaria-induced production of TSLP and IL-25. *P < 0.05; n ¼ 4. (d, e) Effects of siRNA against S100A8
(5 nM) and S100A9 (5 nM) on Alternaria-induced production of TSLP and IL-25. *P < 0.05; n ¼ 4.
T. Kato et al. / Allergology International xxx (2016) 1e9 7stimulate TSLP and IL-25 secretion in epithelial cells.17,18 In addi-
tion, we revealed that other innate immune-stimulatory molecules,
such as TLR4 and RAGE, were also involved in the Alternaria-
induced TSLP and IL-25 production. TLRs, such as TLR2 and TLR4,
play important roles in both innate and adaptive immunity to
fungi.33 Interestingly, a non-enzymatic mite allergen, Der p 2, likely
stimulates an innate immune response through TLR4 by molecular
mimicry of a lipid-recognition protein, MD-2.34 Inhalation of a TLR4
antagonist targeting exposed epithelial cells suppressed the salient
features of asthma, including bronchial hyperreactivity.35 In NHBE
cells, HMGB1 bound to TLR4 and RAGE, and also induced the
expression and secretion of TSLP via RAGE by activating p38 MAPK
and ERK1/2.36 Another investigator also reported that protease al-
lergens, such as papain, induce the expression of IL-25 and TSLP via
the MAPK pathway in primary lung epithelial cells of mice.17 As
such, several receptors, including PARs, TLRs and RAGE, may be
involved in both the recognition and initiation of immune re-
sponses to environmental allergens. Interestingly, analyses of PAR-
2 and TLR4 signal transduction suggest that these receptors may
physically interact and cooperate to produce inﬂammatory re-
sponses.37 Taken together, these ﬁndings suggest that innate im-
mune receptors, such as PARs, TLRs and RAGE, cooperate and
regulate allergen-induced responses in airway epithelial cells.Please cite this article in press as: Kato T, et al., The effect of calprotectin o
International (2016), http://dx.doi.org/10.1016/j.alit.2016.06.011A high concentration of calprotectin over 0.1 mM (>3.6 mg/ml)
has been shown to promote the expression of pro-inﬂammatory
mediators, including IL-6, IL-8 and TNFa, in human keratino-
cytes.3 High extracellular concentrations of calprotectin are found
in the serum and at inﬂammatory sites of patients with autoim-
mune disease, such as arthritis, systemic lupus erythematosus and
Crohn's disease.12e14 In this study, high concentrations of calpro-
tectin (>10 mg/ml) alone induced IL-8 production, not IL-25 and
TSLP production. However, the calprotectin by adding ATP induced
TSLP and IL-25 production. These results indicated that the com-
bination of ATP and calprotectin is involved in Th2-type airway
inﬂammatory responses. Further studies will be needed to thor-
oughly understand the physiological relevance of ATP and
calprotectin.
A previous report also showed that the calprotectin level was
lower in the epithelium of polyp tissues and the nasal lavage ﬂuid of
chronic rhinosinusitis with nasal polyp patients when compared to
healthy controls.10 However, the calprotectin concentration was
signiﬁcantly increased in polyp tissues.10,38 They discussed the
diminished calprotectin in nasal epithelial cells induces a lack of
innate host defense as an antimicrobial or antifungal effect in pa-
tients of CRS. Similarly, in the present study, the calprotectin level
was signiﬁcantly decreased in the unstimulated epithelial cells ofn TSLP and IL-25 production from airway epithelial cells, Allergology
Fig. 6. Calprotectin concentrations in cell lysates and in cell-free supernatants of cultured PNE cells. (a) Calprotectin concentrations in cell lysates of unstimulated PNE cells from UT
or NPs. *P < 0.05 (control: n ¼ 10, NECRS: n ¼ 15, ECRS n ¼ 16). (b) Calprotectin concentrations in cell lysates of unstimulated PNE cells from IT. *P < 0.05 (control: n ¼ 8, AR: n ¼ 17).
(c) Calprotectin concentrations in cell-free supernatants of cultured PNE cells stimulated by 24 h of incubation with Alternaria (200 mg/ml), HDM (100 mg/ml) or protease from
S. aureus (1 mg/ml). *P < 0.05 (control: n ¼ 4, NECRS: n ¼ 8, ECRS n ¼ 8).
T. Kato et al. / Allergology International xxx (2016) 1e98the nasal polyps from ECRS patients. However, allergen-induced
calprotectin production was signiﬁcantly increased in the PNE
cells from ECRS patients when compared to those from NECRS
patients or the control subjects. Previous studies suggested that
soluble gp130 (sgp130), a natural inhibitor of IL-6 transsignaling, is
increase in polyp tissues from CRS with NPs (CRSwNP) patients.39
Sgp130 Levels in polyp tissues from CRSwNP patients were posi-
tively correlated with aging. In addition, calprotectin levels in nasal
lavage ﬂuids were negatively correlated with aging.10,40,41 Because
IL-6 trans-signaling is one of calprotectin production pathway,40
the increased sgp130 may decrease calprotectin expression in the
epithelial cells via inhibition IL-6 trans-signaling. In contrast,
increased production of calprotectin against the protease activity of
allergens in the NPs of ECRS may be derived to the dysfunction of
mucosal barrier or the decreased antimicrobial responses, but not
to IL-6 trans-signaling. Further studies are needed to investigate the
factors regulating calprotectin.
In the present study, calprotectin was found to be in the
allergen-induced production of TSLP and IL-25 in airway epithelial
cells. Although the pathogenesis of ECRS remains unclear, increased
protein levels and mRNA expression of TSLP and IL-25 have been
reported in the epithelial cells of NPs from ECRS patients. Increased
epithelial tissue expression of TSLP and IL-25 has also been
conﬁrmed by immunoﬂuorescent staining.42 These results indicate
that epithelial cell-derived TSLP and IL-25 may be involved in the
development of ECRS, and that calprotectin enhances and modu-
lates these inﬂammatory responses in airway epithelial cells.
In conclusion, these ﬁndings provide new mechanistic insight
into the development of allergen-induced immune responses andPlease cite this article in press as: Kato T, et al., The effect of calprotectin o
International (2016), http://dx.doi.org/10.1016/j.alit.2016.06.011the pathogenesis of ECRS, suggesting that calprotectin may be one
of the key players in airway Th2-type inﬂammation.
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